Mederi Therapeutics manufactures and markets innovative medical devices that deliver radio frequency energy to treat disease. Mederi Therapeutics holds over 80 patents in the use of RF energy for treatment of disease states affecting the human digestive system. The first two products — Secca, for treatment of fecal incontinence (FI) and Stretta, for treatment of gastroesophageal reflux disease (GERD) — have demonstrated clinical effectiveness in numerous studies. All Mederi therapies are outpatient (same day), minimally invasive (no incisions or scars) and promote rapid recovery for patients. Mederi Therapeutics is located in Greenwich, Connecticut.